How Much Bone Loss Before Osteoporosis Shows Up on an X-ray?
By Dr. Yi-Cheng Wu · Reviewed June 21, 2026
A plain X-ray only shows osteoporosis once more than 30% of bone has been lost; dual-energy X-ray absorptiometry (DXA) is the gold standard for diagnosing osteoporosis.
People often ask whether an X-ray can also check for osteoporosis. According to past research, more than 30% of bone must be lost before a plain X-ray clearly shows reduced bone density, so an X-ray is not the gold-standard tool for diagnosing osteoporosis. It can, however, pick up abnormalities through changes in bone density, trabecular pattern, and bone shape, and a lateral spine X-ray can show whether a compression fracture is present. The current gold standard for diagnosing osteoporosis is dual-energy X-ray absorptiometry (DXA); quantitative ultrasound or peripheral bone density measurement serve only as initial screening. Whether further testing is needed and how to follow up still depend on a physician's assessment of individual risk factors.
The question I run into most often in clinic is: doctor, I just had an X-ray today, could you also check whether I have osteoporosis?
An X-ray is not the gold-standard test for diagnosing osteoporosis, but it can hint at osteoporosis through changes in bone density, changes in the trabecular pattern, and changes in bone shape. According to past research, more than 30% of bone must be lost before reduced bone density shows clearly on a plain X-ray. Beyond what a standard X-ray shows, a lateral spine X-ray can also reveal whether a compression fracture is present.
Osteoporosis is a condition that has drawn more and more attention over the past few decades, because as lifespans lengthen, its prevalence, alongside cardiovascular disease, is now among the highest in the world.
According to statistics from Taiwan, among adults over 65, the recorded rate of vertebral compression fractures is 19.8% in women, roughly one in five, and 12.5% in men, roughly one in eight. According to past data from the National Health Insurance Administration, about 30% of women with osteoporosis received treatment, and for men the figure was only 10%. Osteoporosis has known risk factors, and risk and screening can be assessed based on the individual patient’s situation.
Main clinical risk factors
- Age: over 65
- Sex: postmenopausal women
- Low body mass index (BMI): under 18.5
- Fractures, especially of the hip, spine, vertebrae, or wrist
- Height loss: more than 4 cm
- Parental history of hip fracture
- Current smoking
- Excessive alcohol use
- Secondary osteoporosis: requires blood tests for blood cells, liver and kidney function, blood calcium and phosphate, vitamin D, and parathyroid, thyroid, and sex hormones.
- Medications
- Prolonged bed rest, frailty, or low activity: spinal cord injury, Parkinson’s disease, stroke, and similar conditions
Tools for measuring bone density
Dual-energy X-ray absorptiometry (central skeleton)
This is currently the gold standard for diagnosing osteoporosis. DXA is an X-ray machine that produces two low-energy X-rays; besides measuring bone density, it can also analyze body composition and measure muscle and fat mass. Note that bone density values from different machines cannot be directly compared.
Quantitative ultrasound or peripheral bone density measurement
The heel is a research-validated ultrasound site that can predict fragility fractures in postmenopausal women and in men over 65, but there is not yet consensus on the diagnostic criteria. For now it serves only as an initial screening tool and is not recommended as a test for diagnosing osteoporosis or tracking treatment.
Causes of osteoporosis
Primary: mostly related to age
Secondary causes include:
- Endocrine and metabolic diseases: diabetes, acromegaly, growth hormone deficiency, hyperparathyroidism or hyperthyroidism, and similar conditions
- Nutritional and gastrointestinal diseases: alcohol dependence, hypocalcemia, chronic liver disease, vitamin D deficiency, and similar conditions
- Medications: antiepileptic drugs, chemotherapy/immunosuppressants, corticosteroids, heparin, lithium, proton pump inhibitors, and similar drugs
- Other diseases: HIV/AIDS, ankylosing spondylitis, chronic obstructive pulmonary disease, major depression, cancer, rheumatoid arthritis, and similar conditions
Following up bone density
For people not on active treatment: repeat measurement within one year is not recommended (steroid-induced osteoporosis is an exception); follow-up and measurement are generally suggested after two years.
For those on ongoing medication: it takes more than a year for a drug to show its effect in reducing fractures, so treatment should be used for at least one year, ideally more than two years, before the next follow-up.
Using the same machine to measure: a change of 3 to 6% at the hip or an improvement of 2 to 4% or more at the lumbar spine is considered a significant improvement.
Summary
Osteoporosis is a problem everyone may face during aging. In recent years, through the efforts of osteoporosis societies and hospitals, it has gradually gained attention and treatment. Even so, many people, after hearing about osteoporosis treatment and explanations, still choose only to take calcium tablets and get some sun. That is like a house whose steel reinforcement is nearly breaking while only a little concrete is added, which may offer limited help for how osteoporosis develops afterward.
Frequently asked questions
How much bone has to be lost before a plain X-ray can show it?
According to past research, a plain X-ray only clearly shows reduced bone density once more than 30% of bone has been lost, so an X-ray has limited sensitivity for early osteoporosis and is not the gold-standard diagnostic tool.
What are the main clinical risk factors for osteoporosis?
They include age over 65, being a postmenopausal woman, a BMI under 18.5, a prior hip or spine fracture, a height loss of more than 4 cm, a parental history of hip fracture, smoking, excessive alcohol use, and prolonged bed rest or certain medications. Whether screening is needed still depends on a physician's assessment of the individual situation.
What is the tool for diagnosing osteoporosis?
Dual-energy X-ray absorptiometry (DXA, central skeleton) is currently the gold standard for diagnosing osteoporosis; quantitative ultrasound or peripheral bone density measurement serve only as initial screening and are not recommended on their own as the basis for diagnosis or for tracking treatment.
How often should bone density be checked?
For people not on active treatment, follow-up is generally suggested after about two years (steroid-induced osteoporosis is an exception); for those on ongoing medication, because the drug effect takes more than a year to appear, follow-up is usually suggested after at least one year, ideally two years or more. The actual follow-up interval still depends on a physician's individual assessment.
This article is also available in the original Chinese, with the full reference list.
閱讀中文原文 · Read in Chinese